Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Clinical ACO phenotypes: Description of a heterogeneous entity.

Lainez S, Court-Fortune I, Vercherin P, Falchero L, Didi T, Beynel P, Piperno D, Frappe E, Froudarakis M, Vergnon JM, Devouassoux G.

Respir Med Case Rep. 2019 Aug 27;28:100929. doi: 10.1016/j.rmcr.2019.100929. eCollection 2019.

2.

Acute Respiratory Failure in Obesity-Hypoventilation Syndrome Managed in the ICU.

Chebib N, Nesme P, Freymond N, Argaud L, Rimmelé T, Bohé J, Devouassoux G, Souquet PJ, Guérin C.

Respir Care. 2019 Sep 10. pii: respcare.06901. doi: 10.4187/respcare.06901. [Epub ahead of print]

PMID:
31506342
3.

[Diffuse infiltrative lung disease, pericarditis, pleural effusion and ceritinib hypersensitivity].

Gaillard CM, Chumbi-Flores W, Gaillot-Durand L, Craighero F, Devouassoux G, Kiakouama-Maleka L.

Rev Mal Respir. 2019 Sep;36(7):902-905. doi: 10.1016/j.rmr.2019.05.040. Epub 2019 Jul 4. French.

PMID:
31280988
4.

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.

Chapman KR, Albers FC, Chipps B, Muñoz X, Devouassoux G, Bergna M, Galkin D, Azmi J, Mouneimne D, Price RG, Liu MC.

Allergy. 2019 May 2. doi: 10.1111/all.13850. [Epub ahead of print]

PMID:
31049972
5.

Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis.

Calender A, Lim CX, Weichhart T, Buisson A, Besnard V, Rollat-Farnier PA, Bardel C, Roy P, Cottin V, Devouassoux G, Finat A, Pinson S, Lebecque S, Nunes H, Israel-Biet D, Bentaher A, Valeyre D, Pacheco Y; in the frame of GSF (Group Sarcoidosis France).

Eur Respir J. 2019 Aug 1;54(2). pii: 1900430. doi: 10.1183/13993003.00430-2019. Print 2019 Aug. No abstract available.

PMID:
31023854
6.

Asthma patients' perception on their care pathway: a qualitative study.

Hannane A, Misane L, Devouassoux G, Colin C, Letrilliart L.

NPJ Prim Care Respir Med. 2019 Apr 2;29(1):9. doi: 10.1038/s41533-019-0121-2.

7.

Changes in Persistent Asthma Care and Outcomes From 2006 to 2016 in France.

Belhassen M, Nolin M, Nibber A, Ginoux M, Devouassoux G, Van Ganse E.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1858-1867. doi: 10.1016/j.jaip.2019.02.025. Epub 2019 Mar 2.

8.

[Patients in the IDEAL cohort: A snapshot of severe asthma in France].

Taillé C, Pison C, Nocent C, Devouassoux G, Prud'homme A, Gruber A, Gunsoy N, Albers F.

Rev Mal Respir. 2019 Feb;36(2):179-190. doi: 10.1016/j.rmr.2018.10.005. Epub 2018 Nov 11. French.

PMID:
30429093
9.

[Acquired hemophilia A revealing lung cancer].

Cuilleron J, Mas P, Kiakouama L, Gaillot-Durand L, Seve P, Devouassoux G.

Rev Mal Respir. 2018 Sep;35(7):727-730. doi: 10.1016/j.rmr.2017.08.005. Epub 2018 Aug 8. French.

PMID:
30098880
10.

An elastase activity reporter for Electronic Paramagnetic Resonance (EPR) and Overhauser-enhanced Magnetic Resonance Imaging (OMRI) as a line-shifting nitroxide.

Jugniot N, Duttagupta I, Rivot A, Massot P, Cardiet C, Pizzoccaro A, Jean M, Vanthuyne N, Franconi JM, Voisin P, Devouassoux G, Parzy E, Thiaudiere E, Marque SRA, Bentaher A, Audran G, Mellet P.

Free Radic Biol Med. 2018 Oct;126:101-112. doi: 10.1016/j.freeradbiomed.2018.08.006. Epub 2018 Aug 6.

PMID:
30092349
11.

Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France).

BMC Med Genomics. 2018 Mar 6;11(1):23. doi: 10.1186/s12920-018-0338-x.

12.

Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.

Perino E, Freymond N, Devouassoux G, Nicolas JF, Berard F.

Ann Allergy Asthma Immunol. 2018 Jun;120(6):664-666. doi: 10.1016/j.anai.2018.02.018. Epub 2018 Feb 23. No abstract available.

PMID:
29481891
13.

COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.

Kessler R, Casan-Clara P, Koehler D, Tognella S, Viejo JL, Dal Negro RW, Díaz-Lobato S, Reissig K, Rodríguez González-Moro JM, Devouassoux G, Chavaillon JM, Botrus P, Arnal JM, Ancochea J, Bergeron-Lafaurie A, De Abajo C, Randerath WJ, Bastian A, Cornelissen CG, Nilius G, Texereau JB, Bourbeau J.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701612. doi: 10.1183/13993003.01612-2017. Print 2018 Jan.

14.

[Pulmonary embolism as a presentation of nephrotic syndrome].

Fraisse C, Nouvier M, Lainez S, Nesme P, Ernesto S, Devouassoux G.

Rev Mal Respir. 2017 Sep;34(7):765-769. doi: 10.1016/j.rmr.2016.12.002. Epub 2017 Aug 25. French.

PMID:
28844809
15.

Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.

Girodet PO, Jasnot JY, Le Gros V, Decuypère L, Cao W, Devouassoux G.

Respir Med. 2017 Jul;128:92-101. doi: 10.1016/j.rmed.2017.05.010. Epub 2017 May 24.

16.

Hypersensitivity and respiratory allergies in children and adults. Asthma, rhinitis

Perino É, Amat F, Folliet L, Freymond N, Chatté G, Devouassoux G, Just J, Pacheco Y.

Rev Prat. 2017 Jun;67(6):e281-e292. French. No abstract available.

PMID:
30512756
17.

Asthma: some definitions

Chatté G, Devouassoux G, Just J, Pacheco Y.

Rev Prat. 2017 Jun;67(6):e280. French. No abstract available.

PMID:
30512755
18.

[Therapeutic adherence in asthma in France: A general review].

Laforest L, Belhassen M, Devouassoux G, Didier A, Letrilliart L, Van Ganse É.

Rev Mal Respir. 2017 Mar;34(3):194-222. doi: 10.1016/j.rmr.2016.03.013. Epub 2017 Mar 28. Review. French.

PMID:
28359651
19.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group.

Orphanet J Rare Dis. 2016 Dec 3;11(1):165.

20.

Neutrophil elastase cleaves epithelial cadherin in acutely injured lung epithelium.

Boxio R, Wartelle J, Nawrocki-Raby B, Lagrange B, Malleret L, Hirche T, Taggart C, Pacheco Y, Devouassoux G, Bentaher A.

Respir Res. 2016 Oct 17;17(1):129.

21.

Long-Term Inhaled Corticosteroid Adherence in Asthma Patients with Short-Term Adherence.

Laforest L, Belhassen M, Devouassoux G, Didier A, Ginoux M, Van Ganse E.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):890-899.e2. doi: 10.1016/j.jaip.2016.07.008.

PMID:
27587320
22.

[How to consider triggers and comorbid conditions in severe asthma in adults].

Barnig C, Veaudor M, Gautier C, Margelidon-Cozzolino V, Pigearias B, Devouassoux G, Raherison C, De Blay F, Chanez P.

Presse Med. 2016 Nov;45(11):1030-1042. doi: 10.1016/j.lpm.2016.07.020. Epub 2016 Aug 18. Review. French.

PMID:
27544706
23.

Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.

Laforest L, Roche N, Devouassoux G, Belhassen M, Chouaid C, Ginoux M, Van Ganse E.

Respir Med. 2016 Aug;117:33-9. doi: 10.1016/j.rmed.2016.05.019. Epub 2016 May 20.

24.

[Effects of fine particulate matter from on bronchial epithelial cells].

Aloui R, Magne F, Devouassoux G, Deverchere J, Ritter P, Bentaher A, Pacheco Y.

Rev Mal Respir. 2016 Nov;33(9):767-774. doi: 10.1016/j.rmr.2016.02.010. Epub 2016 May 4. French.

PMID:
27157066
25.

Erratum to: Prescribed therapy for asthma: therapeutic ratios and outcomes.

Laforest L, Licaj I, Devouassoux G, Eriksson I, Caillet P, Chatte G, Belhassen M, Van Ganse E.

BMC Fam Pract. 2016 Jan 25;17:5. doi: 10.1186/s12875-016-0404-4. No abstract available.

26.

[COPD: An early disease].

Margelidon-Cozzolino V, Chbini K, Freymond N, Devouassoux G, Belaaouaj A, Pacheco Y.

Rev Pneumol Clin. 2016 Feb;72(1):49-60. doi: 10.1016/j.pneumo.2015.08.002. Epub 2015 Dec 3. Review. French.

PMID:
26657351
27.

[Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab].

Romand P, Kelkel E, Saint-Raymond C, Glas N, Caillaud D, Devouassoux G.

Rev Mal Respir. 2016 May;33(5):397-400. doi: 10.1016/j.rmr.2015.07.005. Epub 2015 Sep 4. French.

PMID:
26346416
28.

Prescribed therapy for asthma: therapeutic ratios and outcomes.

Laforest L, Licaj I, Devouassoux G, Eriksson I, Caillet P, Chatte G, Belhassen M, Van Ganse E.

BMC Fam Pract. 2015 Apr 14;16:49. doi: 10.1186/s12875-015-0265-2. Erratum in: BMC Fam Pract. 2016 Jan 25;17:5.

29.

[Aspirin hypersensitivity: characteristics and diagnostic approach].

Baudrand H, Zaouche S, Dubost R, Carsin A, Chatte G, Freymond N, Piperno D, Dubreuil C, Froehlich P, Pacheco Y, Devouassoux G.

Rev Mal Respir. 2015 Mar;32(3):221-8. doi: 10.1016/j.rmr.2014.04.100. Epub 2014 Jun 25. French.

PMID:
25847199
30.

[Deliberate interruptions and changes of dose of inhaled corticosteroids by asthma patients: "a community pharmacy study"].

Laforest L, Van Ganse É, Devouassoux G, Chatté G, Tamberou C, Belhassen M, Chamba G.

Rev Mal Respir. 2015 Jan;32(1):8-17. doi: 10.1016/j.rmr.2014.04.103. Epub 2014 Aug 8. French.

PMID:
25618199
31.

Relative exposure to controller therapy and asthma exacerbations: a validation study in community pharmacies.

Laforest L, Licaj I, Devouassoux G, Chatté G, Belhassen M, Van Ganse E, Chamba G.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):958-64. doi: 10.1002/pds.3668. Epub 2014 Jun 19.

PMID:
24946177
32.

Unopposed cathepsin G, neutrophil elastase, and proteinase 3 cause severe lung damage and emphysema.

Guyot N, Wartelle J, Malleret L, Todorov AA, Devouassoux G, Pacheco Y, Jenne DE, Belaaouaj A.

Am J Pathol. 2014 Aug;184(8):2197-210. doi: 10.1016/j.ajpath.2014.04.015. Epub 2014 Jun 12.

PMID:
24929239
33.

Asthma drug ratios and exacerbations: claims data from universal health coverage systems.

Laforest L, Licaj I, Devouassoux G, Chatte G, Martin J, Van Ganse E.

Eur Respir J. 2014 May;43(5):1378-86. doi: 10.1183/09031936.00100113.

34.

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.

Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, Cameron R, Shoaib M, Lawrence D, Young D, McBryan D; INVIGORATE investigators.

Lancet Respir Med. 2013 Sep;1(7):524-33. doi: 10.1016/S2213-2600(13)70158-9. Epub 2013 Aug 21.

PMID:
24461613
35.

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y, Devouassoux G, Ferry T, Miyara M, Bouvry D, Valeyre D, Gorochov G, Blankenship D, Saadatian M, Vanhems P, Beynon H, Vancheeswaran R, Wickremasinghe M, Chaussabel D, Banchereau J, Pascual V, Ho LP, Lipman M, O'Garra A.

PLoS One. 2013 Aug 5;8(8):e70630. doi: 10.1371/journal.pone.0070630. Print 2013. Erratum in: PLoS One. 2013;8(8).doi: 10.1371/annotation/7d9ec449-aee0-48fe-8111-0c110850c0c1. Dominique, Valeyre [corrected to Valeyre, Dominique].

36.

Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.

Pacheco Y, Freymond N, Devouassoux G.

J Asthma. 2014 Feb;51(1):1-17. doi: 10.3109/02770903.2013.822081. Epub 2013 Aug 2. Review.

PMID:
23834429
37.

Physicians' knowledge and practice of lung cancer screening: a cross-sectional survey comparing general practitioners, thoracic oncologists, and pulmonologists in France.

Couraud S, Girard N, Erpeldinger S, Gueyffier F, Devouassoux G, Llorca G, Souquet PJ; Lyon Lung Cancer Screening Workgroup.

Clin Lung Cancer. 2013 Sep;14(5):574-80. doi: 10.1016/j.cllc.2013.05.003. Epub 2013 Jul 3.

PMID:
23830707
38.

A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Garcia G, Magnan A, Chiron R, Contin-Bordes C, Berger P, Taillé C, Devouassoux G, de Blay F, Couderc LJ, Didier A, O'Callaghan DS, Girodet PO, Bourdeix I, Le Gros V, Humbert M.

Chest. 2013 Aug;144(2):411-419. doi: 10.1378/chest.12-1961.

PMID:
23579324
39.

Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy.

Tissot C, Carsin A, Freymond N, Pacheco Y, Devouassoux G.

Eur Respir J. 2013 Jan;41(1):246-7. doi: 10.1183/09031936.00107912. No abstract available.

40.

Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease.

Laforest L, Licaj I, Devouassoux G, Hartwig S, Marvalin S, Van Ganse E.

Chron Respir Dis. 2013 Feb;10(1):11-8. doi: 10.1177/1479972312464245. Epub 2012 Nov 13.

PMID:
23149384
41.

Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.

Beaussant Cohen S, Fenneteau O, Plouvier E, Rohrlich PS, Daltroff G, Plantier I, Dupuy A, Kerob D, Beaupain B, Bordigoni P, Fouyssac F, Delezoide AL, Devouassoux G, Nicolas JF, Bensaid P, Bertrand Y, Balabanian K, Chantelot CB, Bachelerie F, Donadieu J.

Orphanet J Rare Dis. 2012 Sep 25;7:71. doi: 10.1186/1750-1172-7-71.

42.

[Physiopathology of aspirin intolerant asthma].

Carsin A, Bienvenu J, Pacheco Y, Devouassoux G.

Rev Mal Respir. 2012 Feb;29(2):118-27. doi: 10.1016/j.rmr.2011.11.014. Epub 2012 Feb 4. Review. French.

PMID:
22405107
43.

[Montelukast in the treatment of mild to moderate persistent asthma].

Bellecoste V, Devouassoux G, Pacheco Y.

Rev Mal Respir. 2011 Jun;28(6):706-29. doi: 10.1016/j.rmr.2010.12.008. Epub 2011 May 17. Review. French.

PMID:
21742233
44.

[Costs of asthma in France].

Laforest L, Com-Ruelle L, Broquet M, Devouassoux G, Van Ganse E.

Rev Prat. 2011 Mar;61(3):336-8. French. No abstract available.

PMID:
21563407
45.

Allergic bronchopulmonary aspergillosis and omalizumab.

Tillie-Leblond I, Germaud P, Leroyer C, Tétu L, Girard F, Devouassoux G, Grignet JP, Prudhomme A, Dusser D, Wallaert B.

Allergy. 2011 Sep;66(9):1254-6. doi: 10.1111/j.1398-9995.2011.02599.x. Epub 2011 Apr 26. No abstract available.

PMID:
21517902
46.

[Multiple spontaneous pneumothoraces revealing Birt-Hogg-Dube syndrome].

Van Denhove A, Guillot-Pouget I, Giraud S, Isaac S, Freymond N, Calender A, Pacheco Y, Devouassoux G.

Rev Mal Respir. 2011 Mar;28(3):355-9. doi: 10.1016/j.rmr.2010.08.015. Epub 2011 Feb 23. French.

PMID:
21482341
47.

Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis.

Coudurier M, Freymond N, Aissaoui S, Calender A, Pacheco Y, Devouassoux G.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):162-6.

PMID:
20560297
48.

[Chronic obstructive pulmonary disease].

Devouassoux G, Freymond N.

Rev Prat. 2010 Apr 20;60(4):559-65. French. No abstract available.

PMID:
20465136
49.

[Lung metastases of epithelioid sarcoma revealed by bilateral spontaneous pneumothorax: a pathological diagnosis].

Barnoud R, Collardeau-Frachon S, de la Roche E, Vasiljevic A, Thomson V, Ranchère D, Devouassoux G, Devouassoux-Shisheboran M.

Ann Pathol. 2010 Apr;30(2):139-42. doi: 10.1016/j.annpat.2010.01.004. Epub 2010 Apr 10. French.

PMID:
20451074
50.

[Assessment of prognostic factors of thoracic synovial sarcoma].

Ngahane BH, Baudrand H, Traverse-Glehen A, Freymond N, Guibert B, Pacheco Y, Devouassoux G.

Rev Mal Respir. 2010;27(1):93-7. doi: 10.1016/j.rmr.2009.11.006. Epub 2009 Nov 28. French.

PMID:
20146960

Supplemental Content

Loading ...
Support Center